Home » Topics » Disease categories and therapies » Infection

Infection
RSS

German lab synthesizes new series of oxazolidinones

Aug. 26, 1999

MacroChem files US patent application for antifungal nail lacquer

Aug. 26, 1999

BioCryst reports initial phase II results from worldwide influenza collaboration

Aug. 25, 1999

Antimycotic agents, triazole derivatives prepared and evaluated by Japanese lab

Aug. 25, 1999

More antiviral agents against CMV discovered at Bayer

Aug. 25, 1999

King completes acquisition from Lilly of U.S. rights to Lorabid

Aug. 25, 1999

Antifungal agent DuP-991 available for licensing from BTG

Aug. 25, 1999

Bayer research yields new anti-CMV compounds

Aug. 24, 1999

Millennium delivers eighth antibacterial drug target to Wyeth-Ayerst

Aug. 24, 1999

Cheil Jedang team synthesizes new oxazolidinones

Aug. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...